- Home
- » Tags
- » Antileukotriene
Top View
- The Evidence on Tiotropium Bromide in Asthma: from the Rationale to the Bedside Dejan Radovanovic1, Pierachille Santus1, Francesco Blasi2 and Marco Mantero2*
- The Controversy Over Long-Acting Beta Agonists: Examining the Evidence
- The Cochrane Database of Systematic Reviews the Cochrane Library, Copyright 2004, the Cochrane Collaboration
- Cox-2) En La Cirrosis
- KFHC DRUG FORMULARY Iii Preface FORMULARY
- Medications Used in Asthma Management 6
- Antileukotrienes and Asthma: Alternative Or Adjunct to Inhaled Steroids?
- Univeristy of California, San Diego
- The Role of Leukotrienes As Potential Therapeutic Targets in Allergic Disorders
- KFHC DRUG FORMULARY Iii Preface FORMULARY
- Paper De La 2-Ciclooxigenasa I La 5-Lipooxigenasa En La Inflamació Hepàtica I Del Teixit Adipós
- Use of Antileukotriene Drugs in Treatment of Children with Bronchial Asthma
- Is There a Rationale and Role for Long-Acting Anticholinergic Bronchodilators in Asthma?
- Management of Paediatric Asthma J Grigg
- Anatomical Classification Guidelines V2006A EPHMRA ANATOMICAL
- ANÁLISIS DE LA PRODUCCION CIENTIFICA SOBRE EL MANEJO TERAPEUTICO DEL PACIENTE ASMATICO (1955-2005) Por Juan Francisco Sánche
- Comparison of Glucocorticoid (Budesonide) and Antileukotriene (Montelukast) Effect in Patients with Bronchial Asthma Determined with Body Plethysmography
- Case Reports Pulmonary Eosinophilia Associated with Montelukast
- The Pharmacogenetics and Pharmacogenomics of Asthma Therapy
- A.N. Belovol 1, S.V. Zajkov 2, I.I. Kniazkova 1, N.V. Kuzminova 3, N.Y. Osovskaya 3
- Pharmacological Treatment of Asthma Today
- G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Actions
- Pharmaceutical Care, the Future of Pharmacy
- The Pharmacogenetics and Pharmacogenomics of Asthma Therapy
- Comparing Biologicals and Small Molecule Drug Therapies for Chronic Respiratory Diseases
- Brief Review: Advances in Therapy with Antileukotriene Drugs
- Effect Antileukotriene Substances (Montelukast) in Patients with Changed Bronchial Reactivity (Non-Reactors, Moderate Reactors and Emphasized Reactors)